British Journal of Dermatology

Research Snippets
pp. i-i(1)

Skin sensitization: strategies for the assessment and management of risk
pp. 267-273(7)
Author: Basketter, D.A.

Safety and efficacy of alefacept, efalizumab, etanercept and infliximab in treating moderate to severe plaque psoriasis: a meta-analysis of randomized controlled trials
pp. 274-285(12)
Authors: Brimhall, A.K.; King, L.N.; Licciardone, J.C.; Jacobe, H.; Menter, A.

Genetics of melanoma predisposition
pp. 286-291(6)
Authors: Lin, J.; Hocker, T.L.; Singh, M.; Tsao, H.

p-Coumaric acid, a constituent of Sasa quelpaertensis Nakai, inhibits cellular melanogenesis stimulated by α-melanocyte stimulating hormone
pp. 292-299(8)
Authors: An, S.M.; Lee, S.I.; Choi, S.W.; Moon, S.-W.; Boo, Y.C.

Dihydrotestosterone inhibits murine hair growth via the androgen receptor
pp. 300-305(6)
Authors: Naito, A.; Sato, T.; Matsumoto, T.; Takeyama, K.; Yoshino, T.; Kato, S.; Ohdera, M.

Skin application of the nonsteroidal anti-inflammatory drug ketoprofen downmodulates the antigen-presenting ability of Langerhans cells in mice
pp. 306-313(8)
Authors: Atarashi, K.; Kabashima, K.; Akiyama, K.; Tokura, Y.

Interaction between p53 codon 72 polymorphism and melanocortin 1 receptor variants on suntan response and cutaneous melanoma risk
pp. 314-321(8)
Authors: Nan, H.; Qureshi, A.A.; Hunter, D.J.; Han, J.

Effects of etanercept on C-reactive protein levels in psoriasis and psoriatic arthritis
pp. 322-330(9)
Authors: Strober, B.; Teller, C.; Yamauchi, P.; Miller, J.L.; Hooper, M.; Yang, Y-C.; Dann, F.

Dermoscopic monitoring of melanocytic skin lesions: clinical outcome and patient compliance vary according to follow-up protocols
pp. 331-336(6)
Authors: Argenziano, G.; Mordente, I.; Ferrara, G.; Sgambato, A.; Annese, P.; Zalaudek, I.

An evidence base for reconsidering current follow-up guidelines for patients with cutaneous melanoma less than 0·5 mm thick at diagnosis
pp. 337-341(5)
Authors: Einwachter-Thompson, J.; MacKie, R.M.

Obesity in psoriasis: leptin and resistin as mediators of cutaneous inflammation
pp. 342-350(9)
Authors: Johnston, A.; Arnadottir, S.; Gudjonsson, J.E.; Aphale, A.; Sigmarsdottir, A.A.; Gunnarsson, S.I.; Steinsson, J.T.; Elder, J.T.; Valdimarsson, H.

Identification of categories at risk for high quality of life impairment in patients with vitiligo
pp. 351-359(9)
Authors: Sampogna, F.; Raskovic, D.; Guerra, L.; Pedicelli, C.; Tabolli, S.; Leoni, L.; Alessandroni, L.; Abeni, D.

Dermoscopy of desmoplastic melanoma: report of six cases
pp. 360-363(4)
Authors: Debarbieux, S.; Ronger-Salve, S.; Dalle, S.; Balme, B.; Thomas, L.

Melanoma histological Breslow thickness predicted by 75-MHz ultrasonography
pp. 364-369(6)
Authors: Guitera, P.; Li, L.X.; Crotty, K.; FitzGerald, P.; Mellenbergh, R.; Pellacani, G.; Menzies, S.W.

Tumour malignancy loss and cell differentiation are associated with induction of gef gene in human melanoma cells
pp. 370-378(9)
Authors: Boulaiz, H.; Prados, J.; Melguizo, C.; Marchal, J.A.; Carrillo, E.; Peran, M.; Rodríguez-Serrano, F.; Martínez-Amat, A.; Caba, O.; Hita, F.; Concha, A.; Aránega, A.

para-Phenylenediamine: the profile of an important allergen. Results of the IVDK
pp. 379-386(8)
Authors: Schnuch, A.; Lessmann, H.; Frosch, P.J.; Uter, W.

Clinical investigation of the novel iron-chelating agent, CP94, to enhance topical photodynamic therapy of nodular basal cell carcinoma
pp. 387-393(7)
Authors: Campbell, S.M.; Morton, C.A.; Alyahya, R.; Horton, S.; Pye, A.; Curnow, A.

Pseudoclonality in cutaneous pseudolymphomas: a pitfall in interpretation of rearrangement studies
pp. 394-402(9)
Authors: Böer, A.; Tirumalae, R.; Bresch, M.; Falk, T.M.

Unexpected diminished innervation of epidermis and dermoepidermal junction in lichen amyloidosus
pp. 403-406(4)
Authors: Maddison, B.; Namazi, M.R.; Samuel, L.S.; Sanchez, J.; Pichardo, R.; Stocks, J.; Maruziva, D.; Yosipovitch, G.

A study examining inter-rater and intrarater reliability of a novel instrument for assessment of psoriasis: the Copenhagen Psoriasis Severity Index
pp. 407-412(6)
Authors: Berth-Jones, J.; Thompson, J.; Papp, K.

The changing face of dermatological practice: 25 years' experience
pp. 413-418(6)
Authors: Benton, E.C.; Kerr, O.A.; Fisher, A.; Fraser, S.J.; McCormack, S.K.A.; Tidman, M.J.

Mortality in Danish patients with nonmelanoma skin cancer, 1978-2001
pp. 419-425(7)
Authors: Jensen, A.Ø.; Bautz, A.; Olesen, A.B.; Karagas, M.R.; Sørensen, H.T.; Friis, S.

Knowledge, attitudes and use of the guidelines for the treatment of moderate to severe plaque psoriasis among Dutch dermatologists
pp. 426-432(7)
Authors: Wakkee, M.; Lugtenberg, M.; Spuls, P.I.; de Jong, E.M.; Thio, H.B.; Westert, G.P.; Nijsten, T.

Distribution of congenital melanocytic naevi and congenital naevus-like naevi in a survey of 3406 Italian schoolchildren
pp. 433-438(6)
Authors: Gallus, S.; Naldi, L.

Evidence of high levels of anxiety and depression in polymorphic light eruption and their association with clinical and demographic variables
pp. 439-444(6)
Authors: Richards, H.L.; Ling, T.C.; Evangelou, G.; Brooke, R.C.C.; Fortune, D.G.; Rhodes, L.E.

Ultraviolet responses of Gorlin syndrome primary skin cells
pp. 445-452(8)
Authors: Brellier, F.; Valin, A.; Chevallier-Lagente, O.; Gorry, P.; Avril, M.-F.; Magnaldo, T.

Evaluation of the efficacy and safety of infliximab on psoriatic nails: an unblinded, nonrandomized, open-label study
pp. 453-456(4)
Authors: Rigopoulos, D.; Gregoriou, S.; Stratigos, A.; Larios, G.; Korfitis, C.; Papaioannou, D.; Antoniou, C.; Ioannides, D.

Serological association of beta and gamma human papillomaviruses with squamous cell carcinoma of the skin
pp. 457-459(3)
Authors: Waterboer, T.; Abeni, D.; Sampogna, F.; Rother, A.; Masini, C.; Sehr, P.; Michael, K.M.; Pawlita, M.

Etanercept combined with methotrexate for high-need psoriasis
pp. 460-463(4)
Authors: Driessen, R.J.B.; van de Kerkhof, P.C.M.; de Jong, E.M.G.J.

Dystrophic epidermolysis bullosa pruriginosa is not associated with frequent FLG gene mutations
pp. 464-469(6)
Authors: Schumann, H.; Has, C.; Kohlhase, J.; Bruckner-Tuderman, L.

Penile lichen sclerosus after allogeneic stem cell transplantation
pp. 470-472(3)
Authors: Au, W-Y.; Yeung, C-K.; Cheung, M-C.; Trendell-Smith, N.J.

The mTOR inhibitor rapamycin significantly improves facial angiofibroma lesions in a patient with tuberous sclerosis
pp. 473-475(3)
Authors: Hofbauer, G.F.L.; Marcollo-Pini, A.; Corsenca, A.; Kistler, A.D.; French, L.E.; Wüthrich, R.P.; Serra, A.L.

A novel missense mutation in the TRPS1 gene underlies trichorhinophalangeal syndrome type III
pp. 476-478(3)
Authors: Tariq, M.; Ahmad, S.; Ahmad, W.

Dermoscopic features of stellate spontaneous pseudoscars in five Japanese men
pp. 479-480(2)
Authors: Kobayashi, K.; Tanaka, M.; Ito, H.; Harada, T.; Aiba, M.

The chemistry and synergy of benzoyl peroxide with clindamycin
pp. 480-481(2)
Authors: Burkhart, C.G.; Burkhart, C.N.

Squamous cell carcinoma arising within folliculitis decalvans
pp. 481-482(2)
Authors: Yip, L.; Ryan, A.; Sinclair, R.

Identical p53 gene mutation in malignant proliferating trichilemmal tumour of the scalp and small cell carcinoma of the common bile duct: the necessity for therapeutic caution?
pp. 482-485(4)
Authors: Nakai, N.; Takenaka, H.; Hamada, S.; Kishimoto, S.

High frequency of vitamin D deficiency among patients with cutaneous lupus erythemathosus
pp. 485-486(2)
Authors: Renne, J.; Werfel, T.; Wittmann, M.

Aquagenic syringeal acrokeratoderma: unusual prominence on the dorsal aspect of fingers?
pp. 486-488(3)
Authors: Yoon, T.Y.; Kim, K.R.; Lee, J.Y.; Kim, M.K.

Palisaded neutrophilic and granulomatous dermatitis in a child with type I diabetes mellitus and coeliac disease
pp. 488-489(2)
Authors: Biswas, A.; Chittari, K.; Gey vanPittius, D.; Stephens, M.; Tan, B.B.

Phacomatosis spilorosea associated with lymphoedema
pp. 489-491(3)
Authors: Jordaan, H.F.; Happle, R.

Making a `point' about the safe disposal of sharps in patients on biological therapies
pp. 491-492(2)
Authors: Hussain, W.; Ogden, S.; Lavery, D.; Griffiths, C.E.M.

Acute generalized exanthematous pustulosis does not always have a drug-related cause
pp. 492-493(2)
Authors: Birnie, A.J.; Litlewood, S.M.

A verruciform xanthoma-like phenomenon in a linear epidermal naevus in the absence of a syndromic association
pp. 493-496(4)
Authors: Ko, J.Y.; Shin, H.; Lee, C.W.

Halo asteatotic eczema localized around a dermatofibroma in acute-onset leg oedema
pp. 496-496(1)
Author: Cox, N.H.

Gastric MALT lymphoma in a patient receiving infliximab for psoriasis
pp. 497-498(2)
Authors: Girard, C.; Guillot, B.; Bessis, D.

Asymptomatic bone marrow involvement in patients presenting with cutaneous marginal zone B-cell lymphoma
pp. 498-500(3)
Authors: Bathelier, E.; Thomas, L.; Balme, B.; Coiffier, B.; Salles, G.; Berger, F.; Ffrench, M.; Sebban, C.; Biron, P.; Dalle, S.

Pachyonychia congenita type 2: abnormal dentition extending into adulthood
pp. 500-501(2)
Authors: Zamiri, M.; McLean, W.H.I.; Hodgins, M.B.; Munro, C.S.

No association between HLA-B and cutaneous reactions to sulphonamides in human immunodeficiency virus-infected patients
pp. 501-503(3)
Authors: Vitezica, Z.G.; Wolkenstein, P.; Lonjou, C.; Eliaszewicz, M.; Sicard, X.; Roujeau, J.-C.; Hovnanian, A.

Simultaneous manifestation of variegate porphyria in monozygotic twins
pp. 503-505(3)
Authors: Borradori, L.; VanTuyll vanSerooskerken, A-M.; Abraham, S.; Hohl, D.; Schneider-Yin, X.; Minder, E.; Frank, J.

Dermatology and junior doctors: an evaluation of education, perceptions and self-assessed competencies
pp. 505-506(2)
Authors: Hussain, W.; Hafiji, J.; Stanley, A.G.; Khan, K.M.

Perifolliculitis capitis abscedens et suffodiens successfully controlled with infliximab
pp. 506-507(2)
Authors: Brandt, H.R.C.; Malheiros, A.P.R.; Teixeira, M.G.; Machado, M.C.R.

Book Review
pp. 507-508(2)
Author: Judodihardjo, Harryono

News and Notices
pp. 508-511(4)

Erratum
pp. 511-511(1)

Corrigendum
pp. 511-511(1)